Differentiating between micronucleus dose-responses induced by whole cigarette smoke solutions with Benchmark Dose...

Area of Science:

• Toxicology
• Genotoxicity Testing
• In Vitro Assays

Background:

• Assessing the genotoxicity of tobacco products is crucial for public health.
• In vitro micronucleus tests (IVMNT) are standard assays for genotoxicity evaluation.
• Dose-response modeling offers a quantitative approach to interpret IVMNT data.

Purpose of the Study:

• To evaluate the utility of dose-response modeling for discriminating between tobacco products based on IVMNT data.
• To assess the genotoxic potential of whole smoke solutions (WSSs) from different cigarette types and smoking conditions.
• To determine if Benchmark Doses (BMDs) can effectively rank the potency of WSSs.

Main Methods:

• Micronucleus responses were measured in L5178Y/Tk+/- mouse lymphoma and TK6 human lymphoblastoid cells.
• Eight WSSs were prepared from two commercial cigarette brands under ISO and HCI smoking conditions.
• Data were analyzed using PROAST software to generate BMDs and confidence intervals, with and without S9 activation.

Main Results:

• IVMNT responses varied significantly based on cigarette type, number smoked, and smoking regimen.
• Mouse lymphoma cells generally showed higher responses than TK6 cells, but both cell types exhibited similar differentiation capabilities.
• BMD potency ranking successfully differentiated between the genotoxicity of various WSSs.

Conclusions:

• Dose-response modeling of IVMNT data is a valuable tool for discriminating tobacco product genotoxicity.
• BMD potency ranking provides a robust method for comparing the relative genotoxic potency of different WSSs.
• The findings support the use of quantitative dose-response analysis in tobacco product safety assessments.